Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV). (Q42999240)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Irina Sominskaya

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Marija Mihailova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Mechthild Boos

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Velta Ose

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Dace Skrastina

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Melanie Fiedler

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Stefan Ross

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Paul Pumpens

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Michael Roggendorf

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sergei Viazov

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

15 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

4369-4377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16574285%20AND%20SRC:MED&resulttype=core&format=json

T cell response in hepatitis C virus infection

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Adaptive immune responses in acute and chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: a preventative vaccine strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Immunology of hepatitis B virus and hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Prospects for a vaccine against the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Virus-like particles as a modular system for novel vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Development of a hepatitis C virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

HBV core particles as a carrier for B cell/T cell epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Behavior of a short preS1 epitope on the surface of hepatitis B core particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

The structure of group II adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051

Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.02.051